KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Inventory (2016 - 2022)

TherapeuticsMD's Inventory history spans 13 years, with the latest figure at $6.7 million for Q3 2022.

  • For Q3 2022, Inventory fell 8.98% year-over-year to $6.7 million; the TTM value through Sep 2022 reached $6.7 million, down 8.98%, while the annual FY2021 figure was $7.6 million, 4.64% down from the prior year.
  • Inventory reached $6.7 million in Q3 2022 per TXMD's latest filing, up from $6.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $14.6 million in Q1 2020 to a low of $1.6 million in Q1 2018.
  • Average Inventory over 5 years is $7.3 million, with a median of $7.5 million recorded in 2019.
  • Peak YoY movement for Inventory: soared 342.89% in 2019, then plummeted 49.71% in 2021.
  • A 5-year view of Inventory shows it stood at $3.3 million in 2018, then skyrocketed by 262.97% to $11.9 million in 2019, then crashed by 32.61% to $8.0 million in 2020, then fell by 4.64% to $7.6 million in 2021, then fell by 12.08% to $6.7 million in 2022.
  • Per Business Quant, the three most recent readings for TXMD's Inventory are $6.7 million (Q3 2022), $6.1 million (Q2 2022), and $9.0 million (Q1 2022).